Showing results (21-30 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|December 10, 2019
Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorderHironobu Ichikawa, Tasuku Miyajima, Yushiro Yamashita, et al.Neuropsychopharmacology Reports|October 10, 2020
High-dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospitalYuji Yamada, Yuma Yokoi, Zui Narita, et al.Neuropsychopharmacology Reports|June 15, 2021
Effects of extended abstinence on cognitive functions in tramadol-dependent patients: A cohort studyShehab H Hassaan, Hossam Khalifa, Alaa M DarwishNeuropsychopharmacology Reports|June 23, 2022
Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reportsAoi Sato, Norio Yasui-Furukori, Yumiko Oda, et al.Neuropsychopharmacology Reports|February 7, 2022
Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open-label pilot studyTakashi Takeda, Yasutaka ChibaNeuropsychopharmacology Reports|February 17, 2022
Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single-center retrospective studyIori Tanahashi, Takafumi Shiganami, Takayuki Iwayama, et al.Neuropsychopharmacology Reports|February 17, 2022
Psychological stress of emergency medical staff after the largest mass murder incident in post-World War II eraHisatoshi Arai, Katsuo Inoue, Takeya Takizawa, et al.Neuropsychopharmacology Reports|April 19, 2022
Role of noradrenergic transmission within the ventral bed nucleus of the stria terminalis in nicotine withdrawal-induced aversive behaviorSaya Arakaki, Masabumi MinamiNeuropsychopharmacology Reports|July 22, 2022
Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy-responsive major depressive disorder: A retrospective 2-year observational studyAkise Umakoshi, Masahiro Takeshima, Yu Itoh, et al.Neuropsychopharmacology Reports|February 28, 2022
Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease-Results of a multicenter open trialKenichi Kashihara, Tetsuya Maeda, Kazuto YoshidaPageof 66